Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

NCT00482846 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Mucositis
Multiple Myeloma

Interventions

BIOLOGICAL: Palifermin
DRUG: melphalan
OTHER: questionnaire administration
PROCEDURE: autologous peripheral blood stem cell transplantation
OTHER: quality-of-life assessment

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]